Understanding how the SOX2 factor affects prostate enlargement in aging men
Function of the Stem Cell Transcription Factor SOX2 in Prostatic Enlargement
This study is looking at how a protein called SOX2 affects the growth of the prostate gland in men over 60, with the goal of finding better ways to treat prostate enlargement.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10765629 on NIH RePORTER |
What this research studies
This research investigates the role of the SOX2 transcription factor in the enlargement of the prostate gland, a common issue for men over 60. The study focuses on how SOX2 influences prostate stem cells and their regeneration pathways, which can lead to health complications. By examining the mechanisms behind SOX2's function, the research aims to uncover new insights that could improve treatment options for prostate enlargement. The approach includes both laboratory experiments and analysis of prostate cell behavior in response to various therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are men over the age of 60 who are experiencing symptoms related to prostate enlargement.
Not a fit: Patients who are younger than 60 or do not have symptoms of prostate enlargement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for prostate enlargement, improving quality of life for many aging men.
How similar studies have performed: Previous research has shown promising results in understanding the role of stem cell factors in organ enlargement, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Vander Griend, Donald James — University of Illinois at Chicago
- Study coordinator: Vander Griend, Donald James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.